Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Gewählte Publikation:
SHR Neuro Krebs Kardio Lipid Stoffw Microb
Oeffl, N; Schober, L; Faudon, P; Schweintzger, S; Manninger, M; Köstenberger, M; Sallmon, H; Scherr, D; Kurath-Koller, S.
Antiarrhythmic Drug Dosing in Children-Review of the Literature.
Children (Basel). 2023; 10(5):
Doi: 10.3390/children10050847
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
- Führende Autor*innen der Med Uni Graz
- Kurath-Koller Stefan
- Öffl Nathalie Maria
- Co-Autor*innen der Med Uni Graz
- Faudon Patrick
- Koestenberger Martin
- Manninger-Wünscher Martin
- Sallmon Hannes
- Scherr Daniel
- Schober Lukas
- Schweintzger Sabrina
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- Antiarrhythmic drugs represent a mainstay of pediatric arrhythmia treatment. However, official guidelines and consensus documents on this topic remain scarce. There are rather uniform recommendations for some medications (including adenosine, amiodarone, and esmolol), while there are only very broad dosage recommendations for others (such as sotalol or digoxin). To prevent potential uncertainties and even mistakes with regard to dosing, we summarized the published dosage recommendations for antiarrhythmic drugs in children. Because of the wide variations in availability, regulatory approval, and experience, we encourage centers to develop their own specific protocols for pediatric antiarrhythmic drug therapy.
- Find related publications in this database (Keywords)
- children
- antiarrhythmic drugs
- arrhythmia
- electrophysiology
- drug dosing